South of Iran Aquaculture Research Institute, Iranian Fisheries Science Research Institute, Agricultural Research Education and Extension Organization (AREEO), Ahvaz, Iran.
Iranian Fisheries Science Research Institute, Agricultural Research Education and Extension Organization (AREEO), Tehran, Iran.
Fish Shellfish Immunol. 2023 Dec;143:109226. doi: 10.1016/j.fsi.2023.109226. Epub 2023 Nov 11.
Vibriosis and Streptococcosis are the most important bacterial diseases that infect Asian seabass (Lates calcarifer) in various stages of its life cycle. Vaccination is a cost-effective strategy to prevent the occurrence of infectious diseases and increase sustainability in the aquaculture industry. This study was aimed to develop and evaluate a killed polyvalent vaccine against Vibrio harveyi, V. alginolyticus and Streptococcus iniae, delivered by intraperitoneal injection in Asian seabass. The fish were divided into three groups with 60 fish in triplicate: I) a control group injected with phosphate-buffered saline (PBS), II) a group vaccinated by polyvalent vaccine (V. alginolyticus + V. harveyi + S. iniae) and III) a group vaccinated with the same polyvalent vaccine plus an oral booster. Immunological parameters and antibody titer were measured before and at three, five-, and eight-weeks post-vaccination. The efficacy of the killed vaccine was assessed five weeks post-vaccination by challenging with each isolate separately. The vaccinated groups had higher survival rate than control group. The highest relative percentage survival rate, 85.71 ± 3.57 % was observed in group III when challenged with V. harveyi. The vaccinated fish produced significantly higher antibody titers against V. alginolyticus, V. harveyi and S. iniae than the control group (P < 0.05). Non-specific immune parameters were significantly enhanced in the vaccinated groups, especially group III, compared to the control. The results demonstrated that the administration of a killed polyvalent vaccine can effectively protect Asian seabass against V. alginolyticus, V. harveyi and S. iniae.
弧菌病和链球菌病是感染亚洲海鲈(Lates calcarifer)在其生命周期各个阶段最重要的细菌性疾病。疫苗接种是一种具有成本效益的策略,可以预防传染病的发生,提高水产养殖业的可持续性。本研究旨在开发和评估一种针对哈维氏弧菌、溶藻弧菌和杀鲑气单胞菌的多价灭活疫苗,并通过腹腔注射的方式在亚洲海鲈中进行评估。将鱼分为三组,每组 60 条鱼,每组重复 3 次:I)对照组注射磷酸盐缓冲盐水(PBS),II)多价疫苗组(溶藻弧菌+哈维氏弧菌+杀鲑气单胞菌)和 III)口服加强剂的多价疫苗组。在免疫前和免疫后 3、5 和 8 周测量免疫参数和抗体滴度。在免疫后 5 周,通过单独挑战每种分离株评估灭活疫苗的功效。与对照组相比,接种组的存活率更高。当受到哈维氏弧菌的挑战时,接种组 III 的相对最高存活率为 85.71±3.57%。接种组对溶藻弧菌、哈维氏弧菌和杀鲑气单胞菌的抗体滴度明显高于对照组(P<0.05)。与对照组相比,非特异性免疫参数在接种组中显著增强,尤其是在接种组 III 中。结果表明,给予多价灭活疫苗可以有效保护亚洲海鲈免受溶藻弧菌、哈维氏弧菌和杀鲑气单胞菌的感染。